Mike Crews
Analyst · Credit Suisse. Please go ahead
Thank you, Belgacem and good morning. Before addressing our third quarter results in detail, I would note that we were pleased with our top line growth, particularly in the EC&S segment. At the same time, our cost performance in certain areas was disappointing which led to a slight decline in adjusted EBITDA. Adjusted free cash flow however was strong in the quarter which we used to repay $80 million in debt and make solid progress toward our deleveraging commitments. I will our review these results in our revised 2018 outlook beginning with Slide 5. Sales increased 9% to approximate 427 million. The EC&S refining services product group had a very good quarter in terms of operating performance and demand for regeneration services and virgin acid. Within PM&C, North American highway sales also contributed to the increase, while performance chemical sales were flat. Foreign currency had a 2% negative impact on our overall revenue growth. Adjusted EBITDA declined 1% to 118 million. Strong results in the EC&S were more than offset by higher cost in PM&C. We do however continue to see price increases in cost pass through provisions that more than offset higher raw material costs. Adjusted EBITDA margin was 26% or 220 basis points below the prior year. The main drivers of the decline were $5 million of unbearable cost absorption in EC&S which impacted margins by 120 basis points. And within performance materials, weaker European highway sales and lower margins in both North America and Europe accounted for another 4.5 million or 100 basis points of the reduction. Next I'll review the performance of each of our business segments, beginning with the environmental catalyst and services segment on Slide 6. Sales increased 21% to approximately $140 million, largely driven by outperformance of refining services. With a major turnaround from the first half behind us, we've benefited from higher volumes in prices in both regeneration services and virgin acid product lines. In addition, polyolefin catalyst volumes continued to deliver double digit growth, offsetting lower than expected hydrocracking and MMA sales, primarily from deferrals to 2019. While strong sales growth improved adjusted EBIDTA, margins declined 240 basis points from the year ago period to 38%. Most of this decline related unfavorable cost absorption in refining services are strong sales depleted inventories. And in silica catalyst, where production was reduced to meet lower MMA demand. This and the continued higher sulfur cost pass through more than offset the benefit to margins from increased refining services demand and lower maintenance and turnaround costs in the quarter. I'll now turn to the performance materials and chemical segment on Slide 7. PM&C sales increased 4% to approximately $288 million. Performance materials increased 10% due to higher thermal drop sales, offsetting lower European highway volumes due to weaker demand. Performance chemical sales were largely flat with the year ago period as price increases were offset by unfavorable foreign currency impact and slower consumer cleaning sales along a strong first half. Adjusted EBITDA was 63 million with margins of nearly 22%. Both decline from the year ago period, largely due to competitive pressure on pricing and increased costs including freight, as we increased volumes and deliver thermal drop to new markets. In addition, we experience higher manufacturing and logistics costs in Europe as we ship to production between Legacy PQ and Silvatech locations to better manage demand. In both cases, we have clear plans in place to address these issues, to improve margins for 2019. And turning to Slide 8 for discussion of our free cash flow. As you may recall, due to seasonality, we typically use cash in the first half of the year to build inventory and then generate most of our cash in the second half of the year. Adjusted free cash flow increased to $75 million more than tripled this time last year. The increase was largely attributable to lower cash interest payments and higher dividends from the Zeolyst joint venture. Cash generated in the quarter was used to repay $80 million of debt, bringing our leverage ratio down to 4.6 times versus 4.9 times at the end of last year. We also extended our interest rate hedging through July 2022 with a new $500 million cap that begins when the current cap ends. With three quarters of the year behind us, I would now like to discuss our updated outlook for the full year 2018 on Slide 9. We now expect full year sales to be in the range of $1.58 billion to $1.6 billion, up from our previous guidance and reflecting the year-to-date benefit of cost pass through. At the segment level, we still expect EC&S sales growth in the mid-single-digit range and PM&C growth in the mid to high single digit rate. We are now forecasting full year adjusted EBITDA in the range of $460 million to $465 million. The lower outlook reflects third quarter financial results and our expectations for a weaker fourth quarter on lower demand performance chemicals and continued cost pressures in performance materials. In addition, hydrocracking catalyst sales are projected to be lower than our original projections and sales that are shifted to 2019. Adjusted EBITDA margin for the year is expected to improve in the fourth quarter and for the year approximate first half of 2018 levels. Notwithstanding the reduction in our adjusted EBITDA outlook, we are tightening our free cash flow outlook for the year to $125 million to $140 million. This is driven by the strong year-to-date cash performance coupled with a reduction in capital spending. And during the fourth quarter, we plan to repay additional term loan debt. So to summarize, we expect high single digit sales growth this year, due to continued healthy underlying demand drivers. We continue to benefit from price exceeding our variable cost through a combination of value pricing and pass through provisions. Plans are in place to eliminate approximately $10 million of higher cost experienced this year and our adjusted free cash flow profile is robust and we will continue to de-lever. With that I will turn the call back Belgacem.